Abstract:Although nanoparticles (NPs) have been demonstrated as promising tools for improving oral absorption of biotherapeutics, most of them still have very limited oral bioavailability. Lyso-endosomal degradation in epithelial cells is one of the important but often-neglected physiological barriers, limiting the transport of cargoes across the intestinal epithelium. We herein reported a solid lipid nanoparticle (SLN) platform with a unique feature of endosomal escape for oral protein drug delivery. The SLNs consisted of a solid-lipid shell, which contained an endosomal escape agent (GLFEAIEGFIENGWEGMIDGWYG, HA2), and an aqueous core that is loaded with insulin (INS HA2-O-SLNs). SLNs without and with the HA2 peptide in the aqueous core (INS SLNs and INS HA2-W-SLNs, respectively) were used as the control groups. Our study showed that INS HA2-O-SLNs effectively facilitated the escape of the loaded insulin from the acidic endosomes, which preserved the biological activity of insulin to a greater extent during the intracellular transport. The spatial location of the HA2 peptide was demonstrated to determine the endosomal escape efficiency. As demonstrated in the intracellular trafficking of SLNs, INS HA2-O-SLNs displayed much less distribution in late endosomes and lysosomes. Meanwhile, insulin in INS HA2-O-SLNs exhibited the highest transepithelial permeation efficiency, with 2.19 and 1.72 folds higher accumulated amount in the basolateral side as compared to that in INS SLNs and INS HA2-W-SLNs. In addition, insulin from INS HA2-O-SLNs exhibited the highest insulin permeation in various regions of small intestines. INS HA2-O-SLNs generated an excellent hypoglycemic response following oral administration in diabetic rats. Thus, such functional SLNs demonstrated a great potency for oral delivery of peptide/protein drugs.

Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity.

Biotinylated Liposomes As Potential Carriers for the Oral Delivery of Insulin.

Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study.

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Enhanced Oral Delivery of Insulin Via Loading in Polysorbate-80 Micelles

β-Lactoglobulin stabilized lipid nanoparticles enhance oral absorption of insulin by slowing down lipolysis

Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.

Investigation of Lectin-Modified Insulin Liposomes As Carriers for Oral Administration

Hypoglycemic Effect of Intravenous Polyethylene Glycol-Coated Liposomal Insulin on Normal Rats

A nano-delivery system based on preventing degradation and promoting absorption to improve the oral bioavailability of insulin

Liposomes Containing Glycocholate As Potential Oral Insulin Delivery Systems: Preparation, in Vitro Characterization, and Improved Protection Against Enzymatic Degradation

Effective Enhancement of Hypoglycemic Effect of Insulin by Liver-Targeted Nanoparticles Containing Cholic Acid-Modified Chitosan Derivative

In Situ Rearranged Multifunctional Lipid Nanoparticles Via Synergistic Potentiation for Oral Insulin Delivery.

Efficient Peroral Delivery of Insulin Via Vitamin B-12 Modified Trimethyl Chitosan Nanoparticles

Improved Oral Delivery of Insulin by PLGA Nanoparticles Coated with 5Β-Cholanic Acid Conjugated Glycol Chitosan

Novel Preparation of PLGA/HP55 Nanoparticles for Oral Insulin Delivery

Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin

Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec)

Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.

Insulin- and Cholic Acid-Loaded Zein/casein-Dextran Nanoparticles Enhance the Oral Absorption and Hypoglycemic Effect of Insulin.